Related Experiment Video
Updated: Mar 28, 2026

Ex Vivo Infection of Murine Epidermis with Herpes Simplex Virus Type 1
Published on: August 24, 2015
Parallel Evolution of Chemokine Binding by Structurally Related Herpesvirus Decoy Receptors
Olga Y Lubman1, Daved H Fremont2
1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Abstract:
A wide variety of pathogens targets chemokine signaling networks in order to disrupt host immune surveillance and defense. Here, we report a structural and mutational analysis of rodent herpesvirus Peru encoded R17, a potent chemokine inhibitor that sequesters CC and C chemokines with high affinity. R17 consists of a pair of β-sandwich domains linked together by a bridging sheet, which form an acidic binding cleft for the chemokine CCL3 on the opposite face of a basic surface cluster that binds glycosaminoglycans. R17 promiscuously engages chemokines primarily through the same N-loop determinants used for host receptor recognition while residues located in the chemokine 40s loop drive kinetically stable complex formation. The core fold adopted by R17 is unexpectedly similar to that of the M3 chemokine decoy receptor encoded by MHV-68, although, strikingly, neither the location of ligand engagement nor the stoichiometry of binding is conserved, suggesting that their functions evolved independently.
Insights
Rodent herpesvirus R17 protein inhibits host immune responses by binding CC and C chemokines. Structural analysis reveals its unique binding mechanism, distinct from similar viral proteins, highlighting independent evolution of immune evasion strategies.
Area of Science:
- Virology and Immunology
- Structural Biology
- Molecular Mechanisms of Pathogenesis
Background:
- Pathogens frequently target host chemokine signaling networks to evade immune surveillance and defense.
- Chemokines are crucial for orchestrating immune cell trafficking and inflammatory responses.
Purpose of the Study:
- To perform structural and mutational analysis of the R17 protein from rodent herpesvirus Peru.
- To elucidate the mechanism by which R17 inhibits chemokine signaling and its evolutionary relationship with other viral chemokine decoys.
Main Methods:
- X-ray crystallography for structural determination of R17.
- Mutational analysis to identify key residues involved in chemokine binding and complex stability.
- Biochemical assays to assess binding affinities and kinetics.
Main Results:
- R17, a potent chemokine inhibitor, binds CC and C chemokines with high affinity.
- Structural analysis revealed R17 possesses a unique architecture with distinct binding sites for chemokines (e.g., CCL3) and glycosaminoglycans.
- Chemokine engagement primarily involves N-loop determinants, with the 40s loop contributing to stable complex formation; R17 shares structural similarity but not functional conservation with MHV-68 M3.
Conclusions:
- R17 effectively neutralizes chemokine activity through a specific structural mechanism, contributing to viral immune evasion.
- The independent evolution of R17 and M3 suggests diverse strategies employed by viruses to manipulate host immunity.
- Understanding R17's structure-function relationship provides insights into viral pathogenesis and potential therapeutic targets.
Related Concept Videos
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Leaky Scanning
Size and Structure of Viral Genomes
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Retrovirus Life Cycles
Viral Structure

